Patel Chem Specialities Limited (BOM:544460)

Market Cap	2.45B
Revenue (ttm)	1.37B +30.6%
Net Income	125.52M +18.8%
EPS	6.63 +8.7%
Shares Out	24.87M
PE Ratio	14.86
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,600
Open	97.15
Previous Close	98.55
Day's Range	94.00 - 99.95
52-Week Range	56.10 - 120.89
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 15, 2026

About Patel Chem Specialities

Patel Chem Specialities Limited manufactures and sells cellulose-based excipients. It offers sodium monochloro acetate; BlowTab, a sodium starch glycolate; Disolwell, a croscaremellose sodium; Swellcal, a carboxymethyl cellulose calcium; Rheollose, a sodium carboxymethyl cellulose; and Hindcell, a microcrystalline cellulose. The company also provides PharLub magnesium stearate, AmyloTab C pregelatinized starcg, and sodium chloro acetate. Its products are used in pharmaceutical, textile, agriculture, surfactants and detergents, food and beverage...

• Industry: Chemicals and Allied Products
• Founded: 2008
• Employees: 136
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544460

Financial Performance

In fiscal year 2026, Patel Chem Specialities's revenue was 1.37 billion, an increase of 30.62% compared to the previous year's 1.05 billion. Earnings were 125.52 million, an increase of 18.81%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 8, 2026

Data Sources Report a data error